Grant R. Zimmermann
- Computational Theory and Mathematics top 0.5%
- Computational Drug Discovery Methods 6
- Molecular Biology top 5%
- RNA and protein synthesis mechanisms 5
- DNA and Nucleic Acid Chemistry 4
- Advanced biosensing and bioanalysis techniques 4
- Receptor Mechanisms and Signaling 3
- Gene Regulatory Network Analysis 2
- Protein Degradation and Inhibitors 2
- Microbiology top 5%
- Pharmacology top 2%
- Pharmacology top 5%
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Joseph LehárCurtis T. KeithAlexis A. BorisyArthur PardiMargaret LeeEdward PriceAndrew KruegerGlenn F. Short
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of the American Chemical Society (2 papers)Nature Biotechnology (1 paper)
- Partner nations
- United StatesPakistanUnited Kingdom
In The Last Decade
Grant R. Zimmermann
15 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Computational Theory and Mathematics 684
- Molecular Biology 2.0k
- Microbiology 134
- Pharmacology 187
- Pharmacology 285
Countries citing papers authored by Grant R. Zimmermann
This map shows the geographic impact of Grant R. Zimmermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant R. Zimmermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant R. Zimmermann more than expected).
Fields of papers citing papers by Grant R. Zimmermann
This network shows the impact of papers produced by Grant R. Zimmermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant R. Zimmermann. The network helps show where Grant R. Zimmermann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Grant R. Zimmermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 1 | |
| 2 | Synergistic drug combinations tend to improve therapeutically relevant selectivitybreakdown → | 2009 | 742 |
| 3 | 2009 | 39 | |
| 4 | Therapeutic selectivity and the multi-node drug target. | 2009 | 15 |
| 5 | 2009 | 63 | |
| 6 | 2008 | 80 | |
| 7 | 2007 | 210 | |
| 8 | Multi-target therapeutics: when the whole is greater than the sum of the partsbreakdown → | 2006 | 866 |
| 9 | Multi-target lead discovery for networked systems | 2004 | 6 |
| 10 | 2003 | 473 | |
| 11 | 2000 | 86 | |
| 12 | 1998 | 38 | |
| 13 | 1997 | 231 | |
| 14 | 1996 | 43 | |
| 15 | 1995 | 116 |
About Grant R. Zimmermann
Grant R. Zimmermann is a scholar working on Computational Theory and Mathematics, Molecular Biology and Microbiology, having authored 15 papers that have together received 3.0k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (6 papers), RNA and protein synthesis mechanisms (5 papers), DNA and Nucleic Acid Chemistry (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), Receptor Mechanisms and Signaling (3 papers), Gene Regulatory Network Analysis (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Computational Theory and Mathematics (684 citations), Molecular Biology (2.0k citations) and Microbiology (134 citations). Grant R. Zimmermann has collaborated with scholars based in United States, Pakistan and United Kingdom. Frequent co-authors include Joseph Lehár, Curtis T. Keith, Alexis A. Borisy, Arthur Pardi, Margaret Lee, Edward Price, Andrew Krueger, Glenn F. Short, Adrian Heilbut and Robert Jenison. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.